Replies to post #43219 on Cann American Corp (CNNA)

[drugmanrx]

ROFLMAO! You are not really that dumb are you?

Different company was occupying the the ticker then the one that is occupying the ticker TODAY.

What happen that company that company couldn't make it, so they tried to reverse merge with another

8k
Item 5.02 Departure of Directors or Certain Officers;
On December 23, 2022, the Company effected an action whereby the previous change of control was rescinded, and the parties were returned to as they were on October 30, 2022. In accordance with the action Alexander Woods-Leo resigned as director and from all offices of the Company and Jason Black was reinstated as Director, President, CEO, Secretary, and Treasurer of the Company.

8K
Item 5.02 Departure of Directors or Certain Officers;
On October 31, 2022, Jason Black resigned as a director and officer of the Company. Mr. Black's departure was not due to any dispute with the Company.
On October 31, 2022, Alexander Woods-Leo was appointed as director, President, CEO and Secretary of the Company. Mr. Alexander Woods-Leo is a published developer and patent holder with over a decade of experience with public companies and financial services.

When Leo could come up with the money, Blacke canceled the reverse merger then reversed merged with Tucker and Prodigy.

8k
On February 1, 2023, Jason Black resigned as director and from all offices of the Company. In consideration of severance to Mr. Black the Company divested its remaining subsidiary, Cannequipt LLC, and assigned its sole control to Mr. Black. The Company also assigned its loan agreements in "Cannagram" to Mr. Black. The Company has retained all ownership and rights to the "C-Juice" lines of CBD and Delta 8 products. The Company has also retained its hemp farming lease agreement in Glencoe, Oklahoma.



Item 1.01 Entry into a Material Definitive Agreement.



On January 30, 2023, the Company entered into a Binding Letter of Intent to acquire Prodigy Stem Cell, LLC as a wholly owned subsidiary of the Company.

8k Item 2.01 Completion of Acquisition or Disposition of Assets.

On March 1, 2023, the Company completed the acquisition of Prodigy Stem Cell, LLC as a wholly owned subsidiary. Prodigy Stem Cell, LLC is a New Jersey based company focused on sales, marketing, and consulting for regenerative medicines.

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On March 1, 2023, the Company appointed Peter Caruso as a Director of the Company. Mr. Caruso has over 20 years of business development experience and is the Founder of Prodigy Stem Cell, LLC.

SMH